Biomedical sciences researcher to present results of clinical trials on personalized chemotherapy

HUNTINGTON, W.Va. – Dr. Pier Paolo Claudio, a researcher at the Marshall University Joan C. Edwards School of Medicine, is traveling to Paphos, Cyprus, next month to present his work to personalize chemotherapy for cancer treatment.

Claudio was invited to give the talk at the 5th International Conference on Recent Advances in Health and Medical Sciences, which will be held July 6-12.

He will be discussing the results of clinical trials conducted at the Edwards Comprehensive Cancer Center. The studies tested ChemoID, a cell culture method he developed with colleague Dr. Jagan Valluri to measure the sensitivity of patients’ tumors to chemotherapy treatment for lung, brain/spine and breast cancer.

He says more evaluation of the technology is needed, but preliminary tests on a small number of patients found ChemoID 100 percent accurate in predicting which drug is more effective in treating patients affected by brain cancer if the tumor-initiating cancer stem cells were evaluated.

Claudio“Oncologists every day face many challenges in determining the best course of therapy for an individual cancer patient,” says Claudio. “The basic problem is that patients with similar diagnoses don’t always respond to the same chemotherapy. This technology we have developed could help physicians select the appropriate chemotherapy for an individual patient—giving them an edge in the fight against cancer.”

He says the good news for cancer patients is that ChemoID may make possible personalized treatment by predicting the most effective drug combination to successfully target that specific patient’s cancer—increasing the chance the drugs will work and perhaps reducing side effects by helping the patient avoid unnecessary drugs.

In addition to presenting his own research at the conference, Claudio will be moderating a session, “Advances in Oncology and Anticancer Research. Cancer Pathology.”

Summaries of the research presented at the meeting will be published in the journal Frontiers in Bioscience.

###

Contact:  Ginny Painter, Communications Director, Marshall University Research Corporation, 304-746-1964 (o) www.marshall.edu/murc

Grant to fund MU’s new cancer research

HUNTINGTON — A new concept in cancer treatment will be future explored at Marshall University thanks to a grant from the National Cancer Institute.

The U.S. Department of Health and Human Services (HHS) National Cancer Institute awarded a $432,369 three-year Academic Research Enhancement Award to the Marshall Vincent-Sollars-2012University Joan C. Edwards School of Medicine to launch a cancer biology research project in “epigenetics,” a relatively new concept in cancer therapies, according to a press release from Rep. Nick Rahall, D-W.Va.

The concept deals with a new chemotheraputic target in cancer treatment, said Dr. Vincent E. Sollars, an associate professor of biochemistry and biology at Marshall.

“It’s a great way for me and the students to get involved in some research I’ve wanted to do for some time,” Sollars said. “We’re targeting leukemia specifically with this grant, but the this could have ramifications on all types of cancers.”

Over the course of the three-year project, Marshall University anticipates involving eight students from undergraduate, master’s and doctoral academic programs, as well as students enrolled in the med school.

Sollars said the medical school also will hire a full time technician through the grant.

MU biomedical students showcase research

BILL ROSENBERGER
The Herald-Dispatch

HUNTINGTON — Medical research that has an opportunity to affect the health and well-being of the general population should be celebrated, which is one of the reasons for the showcase at Pullman Plaza Hotel.

More than a dozen projects by Marshall University biomedical science graduate students and faculty members showcased their work as part of the ninth annual Biomedical Sciences Retreat. The event gives graduate students in the university’s biomedical sciences program an opportunity to share their research, including projects to study the effects of drugs on the kidney, obesity and type 2 diabetes, and how neurons respond to different patterns of neural activity.

Elsa Mangiarua, a professor in the Department of Pharmacology, Physiology and Toxicology, said Ph.D. students get to share their work with each other, while newly admitted Ph.D. students get to see some of the research they will be getting into.

“There are a lot of good projects with positive results in translational research,” said Rachel Murphy, who is a first-year student from Kansas. “It sets the bar high to help medical science advance to the next step. It’s definitely inspiring.”

Marcus_Terneus2013That was also the observation from Marcus Terneus, senior manager of global EH&S occupational toxicology at Mylan Pharmaceuticals. He is a 2006 graduate of the Marshall Ph.D. program and served as the afternoon’s keynote speaker.

“I’m very proud. It’s exciting to see the growth and what projects are going on,” Terneus said. “I keep close eyes on what students are doing.”

He also told the group that the education and research opportunities he received prepared him for what he’s seen during the past seven years.

“It’s given me what I needed to succeed,” he said.

The research also was noted as impressive because of how groundbreaking the results could be. Second-year student Justin Tomblin’s project centered on the link between obesity and breast cancer and how to block the growth of abnormal tissue.

In West Virginia, which has high obesity rates, that kind of research could help quite a few folks, he said.

“It definitely feels like you are doing something that may help friends or relatives,” Tomblin said.

John Maher, the vice president for research at Marshall and executive director of the Marshall University Research Corporation, said after hearing some presentations that Marshall has a very strong biomedical sciences program. He also noted that they are working on relevant and important problems pertaining to regional health care.

Dr. Gary Rankin receives alumni award from Ole Miss

Gary O. Rankin, Ph.D.Dr. Gary O. Rankin, professor and chair of the Department of Pharmacology, Physiology and Toxicology at the Joan C. Edwards School of Medicine, was recently honored by the Department of Medicinal Chemistry at the University of Mississippi School of Pharmacy with its Joseph Sam Distinguished Alumni Award.

Rankin, who graduated with his doctorate from “Ole Miss” in 1976, joined the Marshall University faculty in 1978 after completing postdoctoral work at the Medical College of Ohio, now the University of Toledo. Rankin serves as principal investigator for the National Institutes of Health-funded West Virginia IDeA Network of Biomedical Research Excellence (WV-INBRE) program. He has authored or coauthored more than 100 peer-reviewed manuscripts, eight review articles, 13 book chapters and nearly 200 research presentations at local, regional, national and international meetings.

Rankin was honored in March during a ceremony in Oxford, Miss.

This article was published in this week’s edition of the We Are…Marshall newsletter. (http://www.marshall.edu/wamnewsletter/2013/04/16/dr-gary-rankin-receives-alumni-award-from-ole-miss/)

Racine attends the Society of Toxicology General Meeting in San Antonio, Texas

by M. Allison Wolf

Chris Racine, Ph.D. student, on far leftBiomedical Sciences Ph.D. student Chris Racine recently presented his research at the Society of Toxicology (SOT) General Meeting in San Antonio, Texas. The study Chris presented at this meeting was entitled “Role of renal cytochrome p450 isozymes in the bioactivation of 3,5-dichloroaniline in vitro.” The long term goal of this project is “to determine the biotransformation of 3,5-dichloroaniline (3,5-DCA), mechanisms for bioactivation of 3,5-DCA to nephrotoxic species by the kidney, and if gender differences exist in the susceptibility of the kidney to the toxic effects of 3,5-DCA.”   

The SOT conference, which was held from March 10-14, is the largest toxicology meeting in the world and it brings together scientist in academia, government, and industry from various countries. Dr. Gary Rankin, Chris Racine’s Ph.D. advisor said that, “It is important for students to experience the scientific exchange that happens at a national research conference. There is no substitute for attending such a meeting in person. The meeting also gives the advisor the opportunity to introduce the students to other top scientists and students in their field, and the feedback received at a national presentation can be very helpful for the student’s research projects.”

Congratulations, Chris!

Carper selected for ASBMB Graduate Student Travel Award

by: M. Allison Wolf

Biomedical Sciences Ph.D. candidate Miranda Carper was selected for a graduate student travel award to attend the American Society for Biochemistry and Molecular Biology (ASBMB) Annual Meeting in Boston, Massachusetts. ASBMB is one of six participating societies represented at the 2013 Experimental Biology Conference. The conference will run from April 20-24, and will bring together researchers from all over the world. 

Miranda

The conference is a multidisciplinary scientific meeting and researchers will meet to discuss the new strides made in the fields of: anatomy, physiology, biochemistry, pathology, nutrition, and pharmacology.

The research project Miranda plans to present focuses on a target thought to be a player in the cross talk between p53 and pRB. The objective of her current study is to investigate if this target, regulator of G-protein signaling (RGS16), plays a role in pancreatic cancer cell invasion and migration.

Dr. Pier Paolo Claudio, Miranda’s Ph.D. advisor, is proud of his student’s achievement. “Miranda is driven and works hard. I am thrilled that she has the opportunity to share her research and attend an international conference.” Congrats, Miranda!

Marshall biomedical sciences’ researchers publish e-book on nutrition and cancer

Cover of "Nutrition and Cancer: From Epidemiology to Biology"Researchers at Marshall University’s Joan C. Edwards School of Medicine have collaborated on an electronic book, “Nutrition and Cancer From Epidemiology to Biology,” recently published by Bentham Science Publishers.

This ebook is one of the latest efforts of researchers at the Marshall University Nutrition and Cancer Center.

A collection of scientific articles written by Marshall faculty members and students, the publication was edited by Dr. Richard M. Niles, professor and chairman of the university’s Department of Biochemistry and Microbiology, and Dr. Pier Paolo Claudio, associate professor in the Department of Biochemistry and Microbiology and director of the McKown Translational Genomic Research Institute.

According to the publisher, various estimates suggest that between 30-40% of all human cancers are related to dietary patterns. Strong epidemiological evidence from studies points to dietary constituents that either contribute or protect against the development of various forms of cancer.

This e-book reviews some traditional and relatively new areas of nutrition and cancer. Epidemiological data is combined with molecular biology research and, where available, clinical trial data. The emerging science of “Nutrigenomics” is discussed with chapters on the biological role of various nutrition components from red wine, peppers, green tea, fish oil, cruciferous vegetables, retinoids; and the intersection of nutrition and epigenetics in hematopoiesis.

The publication will be of interest to researchers in the nutrition and cancer fields, physicians in family and community medicine, internal medicine and oncology, and dieticians providing counseling to cancer patients and cancer survivors.

by Ginny Painter
Director of Communications
Marshall University Research Corporation
ginny.painter@marshall.edu
www.marshall.edu/murc